Hepatitis C in Greater Manchester: Report on the Decision Model for Changing Care Pathways


2008 by Carl Ashworth, Commissioning Business Service
The population of Greater Manchester has amongst the highest prevalence of Chronic Hepatitis C virus (HCV) infection in the UK, and the associated health problems are escalating. And yet, at the time of writing HCV services in Greater Manchester did not meet the population need. In order to overcome these shortfalls, this document sets out a proposal that has been put to Greater Manchester PCTs to introduce changes to its patient pathways and service models. This HCV decision model is intended to establish the cost effectiveness of the key changes, and has been built from an NHS-perspective intended to inform a decision by the ten Greater Manchester PCTs on the implementation of improvements to the HCV treatment pathway. The outputs of the model – in terms of an incremental cost effectiveness ratio (ICER) compared to the current pathway – demonstrate the cumulative effect of implementing each stage of improvement as described above.
North West